Figure 1From: BEAT® the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGsThe BEAT®bispecific platform. In A: secretion profile of a BEAT® secreting CHO clone obtained by Caliper analysis of a non-purified supernatant. B: distribution of the heterodimerization level of stable clones at cell line development level. C: BEAT® expression level of 10 selected stable clones. D: BEAT® purification strategy.Back to article page